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Abstract
Childhood adversity affects later health, but the underlying molecular mechanisms are unclear. Although there is some
evidence from animal models and case-control studies of a role for DNA methylation, evidence from human
population-based studies is limited. In two cohorts (mothers from the Avon Longitudinal Study of Parents and
Children, ALSPAC, n= 780 and women from the MRC National Survey of Health and Development, NSHD, n= 552),
we assessed the association of seven adverse childhood experiences (ACEs: parental physical illness, parental mental
illness, parental death, parental separation, suboptimal maternal bonding, childhood illness and child maltreatment) as
well as their combination (ACE score) with genome-wide DNA methylation levels measured using the Illumina
Inﬁnium HumanMethylation450 BeadChip in peripheral blood at mean age 47 years (ALSPAC) and in buccal cells at
age 53 years (NSHD). CpG sites with a genome-wide false discovery rate (FDR) below 0.05 and differentially methylated
regions (DMRs) with one-step Šidák correction p-values below 0.05 in each cohort were examined in the other cohort.
No individual CpG sites replicated across cohorts. However, nine DMRs replicated across cohorts respectively
associated with the ACE score (one region), parental mental illness (two regions), parental physical illness (three
regions) and parental death (three regions). These observations indicate that some adverse childhood experiences,
notably those related to parental health, may leave imprints on peripheral DNA methylation that persist to mid-life.
Introduction
Childhood adversity is related to a broad range of
negative outcomes across the lifespan including poorer
mental and physical health1,2 as well as lower educational
attainment, income and economic participation3,4. The
molecular mechanisms underlying these associations
remain uncertain, although a role for epigenetic marks
has been suggested. DNA methylation, the addition of a
methyl group to a cytosine base that is followed by a
guanine (CpG site)5, is the epigenetic modiﬁcation most
widely analysed in population-based studies. Previous
studies indicate DNA methylation in adulthood can be
affected by environmental factors early in life6,7.
Childhood adversity is related to altered DNA methy-
lation in both animal and human studies (see review8). In
fact, several genome-wide studies of childhood adversity
in humans have identiﬁed associations throughout the
genome6,9–15. Moreover, there is some evidence that
associations near stress-related genes may be relevant for
later life health16,17. However, most previous studies
either focused on candidate genes or sampled from at-risk
populations. One recent genome-wide population-based
study on early-life victimisation stress did not identify
robust changes in DNA methylation18, but did not
examine other forms of childhood adversity (parental
separation, parental mental or physical illness, child
illness).
Therefore, we examine the association between various
types of childhood adversity and genome-wide DNA
methylation in two large population-based cohorts, the
mothers of the Avon Longitudinal Study of Parents and
Children (ALSPAC) and women from the MRC National
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Survey of Health and Development (NSHD). In these
cohorts, previous studies have demonstrated associations
between adversity and health19–23. Given the known co-
occurrence of different types of adversity and the potential
cumulative effects on health24,25, we analyse a count score
of the adverse childhood experiences (ACE) in addition to
exploring whether each different type of childhood
adverse experience was associated with DNA methylation
variation in separate epigenome-wide analyses (EWAS).
Materials and methods
Data
The ALSPAC is a prospective, population-based birth
cohort study that recruited 14,541 pregnant women
resident in Avon, UK, with expected delivery dates
between the 1st April 1991 and 31st December 199226,27.
The mothers, their partners and the index child have been
followed-up through clinics, questionnaires and links to
routine data. The ALSPAC mothers form the participants
for this study. The study website contains details of all the
data that is available through a fully searchable data dic-
tionary (http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/). The Accessible Resource for
Integrated Epigenomic Studies (ARIES) project28 includes
1018 mother-child pairs from ALSPAC that had DNA
methylation measured using the Inﬁnium Human-
Methylation450BeadChip (Illumina, Inc). Our analysis
used DNA methylation proﬁles of peripheral blood col-
lected from mothers at a follow-up clinic (age of partici-
pants ranged from 44 to 50 years (mean= 47.1)). DNA
methylation proﬁles derived from peripheral blood col-
lected during the study pregnancy approximately 18 years
earlier were used to replicate ﬁndings (mean age= 29.1).
Ethical approval was obtained from the ALSPAC Ethics
and Law Committee and the Local Research Ethics
Committees and informed consent was obtained from all
subjects.
The MRC National Survey of Health and Development
(NSHD) is based on a nationally representative sample of
5362 births out of all the single births that took place
within marriage in one week in March 1946 in England,
Scotland and Wales;29 study members have been followed
up 24 times, up to age 6930.
For 810 women, DNA methylation at age 53 years was
measured using the Inﬁnium HumanMethyla-
tion450BeadChip (Illumina, Inc) on buccal epithelial
samples and in a subsample of 156 women also on whole
blood cells (WBC)31. All women gave written informed
consent for their samples to be used in genetic studies of
health, and the Central Manchester Ethics Committee
approved the use of these samples for epigenetic studies of
health in 2012.
Childhood adversity
Seven ACEs were assessed in both ALSPAC and NSHD:
(i) suboptimal maternal bonding, (ii) childhood physical
illness, (iii) parental mental illness, (iv) parental divorce or
separation, (v) parental physical illness or disability, (vi)
parental death in childhood and (vii) child maltreatment.
In ALSPAC child maltreatment was further reﬁned into
ﬁve distinct ACEs, three forms of abuse (sexual, emotional
and physical) and two forms of neglect (emotional and
physical). In ALSPAC, women reported ACEs in retro-
spective questionnaires at study enrolment (during preg-
nancy, mean age 28 years) or soon thereafter. In NSHD,
ACEs were prospectively reported in interviews and
questionnaires by the participants’ mothers up to age 16,
except for parental bonding and maltreatment, which
were self-reported when participants were age 43. All
ACEs were deﬁned as binary indicators of presence/
absence of the adversity. An ACE score was generated by
adding up whether an individual was exposed to the
ACEs, creating a score with a maximum possible value of
seven in NSHD and eleven in ALSPAC (further details in
Supplementary information).
Associations between the ACE score and mental health
have been demonstrated previously in the NSHD
cohort23, but not in the ALSPAC mothers. Therefore, to
demonstrate that the ACE score behaves as expected in
relation to mental health, we examined the association of
the ACE score with depression (deﬁned according to a
score of 13 or more on the Edinburgh Postnatal Depres-
sion Score from questionnaires completed by the mother
when the child was 11 years old), both in the full ALSPAC
cohort and in the subsample included in our EWAS.
DNA methylation
In both cohorts following DNA extraction, DNA was
bisulﬁte converted using the Zymo EZ DNA Methyla-
tionTM kit (Zymo, Irvine, CA, USA). Genome-wide DNA
methylation levels at over 485,000 CpG sites were mea-
sured with the Inﬁnium HumanMethylation450 Bead-
Chip. Both datasets were pre-processed in R version 3.2.4
with the mefﬁl package32, using functional normal-
isation33 to reduce non-biological differences between
probes. After pre-processing, 976 samples and 453,965
probes were available for further analysis in ALSPAC,
while 766 buccal as well as 153 blood samples and 455,971
probes were available for further analysis in NSHD (fur-
ther details in Supplementary information). Methylation
level at a CpG site is expressed as a ‘beta’ value (β-value),
ranging from 0 (no cytosine methylation) to 1 (complete
cytosine methylation). β-Values are reported as percen-
tages. To reduce the inﬂuence of outliers in regression
models, normalized β-values were 90%-Winsorized.
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Epigenome-wide association studies (EWAS)
Epigenome-wide association studies (EWAS) for the
ACE score and each separate ACE were conducted in R
version 3.2.434, using linear regression models with
untransformed methylation beta values as the outcome.
EWAS were conducted separately in each cohort; 8 sepa-
rate EWAS were performed in NSHD (7 individual ACEs
and the ACE score), and 13 EWAS were performed in
ALSPAC (11 individual ACEs, child maltreatment, and
the ACE score). Multiple testing was accounted for by
controlling the false discovery rate (FDR) at 5%, imple-
menting the method by Benjamini and Hochberg35.
All models were adjusted for the age at DNA sampling.
To adjust for technical batch effects, independent surro-
gate variables (ISV) were calculated and included in all
models36. In ALSPAC, Houseman-estimated cell propor-
tions37 were used to adjust for cellular heterogeneity in
blood DNA samples.
As smoking may potentially lie on the causal pathway
between childhood adversity exposure and DNA methy-
lation, adjustment would remove part of the pathway of
interest and could potentially result in collider bias. Thus,
the main analyses were not adjusted for smoking status.
However, the inﬂuence of smoking for the CpGs and
DMRs of interest was examined in a sensitivity analysis by
adding a methylation-based smoking score, derived from
the effect size estimates of the 185 probes with FDR <0.05
in a recent smoking EWAS38, as a covariate to the main
model.
When the ACE score was the exposure, the regression
coefﬁcients in the EWAS model are interpreted as the
difference in mean methylation when the score increases
by one. For the individual ACEs, regression coefﬁcients
are interpreted as the mean difference in methylation
between the adversity exposed and unexposed groups.
Differentially methylated regions
The EWAS results were used to detect differential
methylation across larger regions of the genome with
Comb-P39 (further details in Supplementary information).
Replication
CpGs with FDR <0.05 or DMRs with Šidák-corrected P-
value <0.05 in either ALSPAC or NSHD were examined in
the other cohort.
Enrichment for probes previously reported in literature
To examine whether the top 1000 CpGs in our EWAS
analyses were enriched for CpGs previously reported in
literature, we identiﬁed nine publications that reported
CpG sites on the Illumina Inﬁnium HumanMethyla-
tion450 BeadChip associated with (a form of) childhood
adversity (further details in Supplementary information,
Supplementary Table 5 and the probe lists in
Supplementary data sheet 1). We also included lists for
potentially unreliable probes40,41 and CpGs related to
smoking38. For all lists, enrichment of the previously
reported CpGs in the top 1000 CpGs in our EWAS ana-
lyses was examined using Fisher’s exact test.
Cohort comparison
We compared the associations of adversity in ALSPAC
and NSHD by calculating Pearson’s correlation of the
regression coefﬁcients of the top 1000 CpG sites identiﬁed
by each cohort. For DMRs, correlation was calculated
from the average of the regression coefﬁcients of the
CpGs that were part of a DMR. To calculate an infor-
mative correlation coefﬁcient, the cohort comparison was
only performed if, for a particular ACE, more than three
DMRs were identiﬁed.
Cross-tissue analysis
In a subset of 98 women in NSHD with buccal DNA
and ACE data, who also had blood DNA methylation
measured at the same time point, the tissue speciﬁcity of
childhood adversity related changes in DNA methylation
was examined (cross-tissue subset). Parental mental ill-
ness could not be evaluated in this subsample due to a
lack of cases (see Supplementary Table 4). For each of the
available ACE measures, an EWAS analysis was per-
formed for each tissue type. We then examined the tissue
speciﬁcity of adversity by calculating the correlation of the
regression coefﬁcients for the top 1000 CpGs. For DMRs,
we calculated the correlation of the average of the
regression coefﬁcients of the CpGs that were part of each
DMR. The cross-tissue analysis was only performed if, for
a particular ACE, more than three DMRs were identiﬁed.
Genetic variants near replicated DMRs
In a sensitivity analysis, the inﬂuence of genetic varia-
tion on the association between childhood adversity and
methylation at our DMRs of interest was investigated in
ALSPAC. Genetic data from genome-wide assays (Illu-
mina 660W-quad BeadChip) was available for 700 of the
780 participants in the ALSPAC EWAS analyses26.
For each replicated DMR, we included SNPs as cov-
ariates in the EWAS model that were located within 1MB
(observed and imputed SNPs pruned for independence
(R-squared <0.0001) with a major allele frequency >1%
and less than 3% missing) and were associated (p < 0.05)
with at least one CpG in the DMR.
Results
Characteristics of participants
Complete adversity and DNA methylation data were
available for 780 women in the ALSPAC cohort and 552
women in NSHD. The mean age at DNA methylation
assessment was 47.4 years in ALSPAC, and 53.4 years in
Houtepen et al. Translational Psychiatry           (2018) 8:266 Page 3 of 12
Table 1 Prevalence of childhood adverse experiences in ALSPAC mothers and NSHD participants
ALSPAC NSHD Comparisona
Participants with
complete adversity
data
(n= 8021)
Participants with DNA
methylation data,
included in our analysis
(n= 780)
Participants with
complete adversity
data
(n= 2438)
Participants with DNA
methylation data,
included in our analysis
(n= 552)
p-value
Sex=Male (%) 0 0 51.4 0 n/a
Age clinic (mean (sd)) 47.90 (4.40) 47.14 (4.61) 53.48 (0.50) 53.45 (0.50) <0.001
Smoking (%) <0.001
Never-smoker 53.4 56.3 30.3 33.3
Ex-smoker 35.4 36.2 48.5 47.3
Current-smoker 11.1 7.4 21.2 19.4
Childhood adverse experiences before 17 years
Parent physically ill (%) 25.8 28.6 22.7 25.9 0.308
Parent mentally ill (%) 4.4 5.8 2.2 1.8 0.001
Parents separated (%) 17.7 14.9 5 4.2 <0.001
Parent died (%) 5.9 5.1 6.9 6.3 0.409
Suboptimal maternal
bonding (%)
18.8 15.8 19.3 21.7 0.007
Child illness (%) 5 5.3 15.4 13.4 <0.001
Child maltreatment (%) 24.6 22.2 6.2 6.5 <0.001
Sexual abuse (%) 4.5 3.7 n/a n/a n/a
Physical abuse (%) 3.2 3.1 n/a n/a n/a
Emotional abuse (%) 7.5 8.3 n/a n/a n/a
Physical neglect (%) 1.8 1.2 n/a n/a n/a
Emotional neglect (%) 20.8 19.4 n/a n/a n/a
Adverse Childhood Experiences (ACE) count score (%) <0.001
0 42.4 43.8 45.3 42
1 29 29.4 36.8 41.1
2 14 12.3 13.7 12.7
3 7.4 6.9 3.6 3.4
4 3.5 4 0.6 0.5
5 1.9 1.9 0.1 0.2
6 1 0.9 0 0
7 0.5 0.8 0 0
8 0.2 0 n/a n/a
9 0.1 0 n/a n/a
10 0 0 n/a n/a
aThe difference between the ALSPAC (n= 780) and NSHD (n= 552) participants that were included in our EWAS analyses was tested using a Pearson’s chi-squared
test for categorical variables and an ANOVA for numerical variables
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NSHD. Table 1 shows the prevalence of each type of ACE,
and each category of the ACE score. Parental physical
illness and parental death had similar prevalence in both
cohorts. Parental mental illness, parental separation and
any maltreatment were more prevalent in ALSPAC, and
child illness and suboptimal maternal bonding were more
common in NSHD. Most ACEs had a similar prevalence
in the participants without DNA methylation data, and
the ACE score demonstrated similar associations with
depression in the full cohort of ALSPAC mothers and in
the subsample included in our analysis (see Supplemen-
tary Tables 2–4).
The correlation (Cramér’s V for nominal variables)
between different adverse experiences varied, with ϕc
ranging from 0 to 0.5 in ALSPAC and 0 to 0.1 in NSHD
(Supplementary Figure 3 and 4). In general, correlations
between ACEs were considerably lower in NSHD than
ALSPAC.
Individual CpGs
In both NSHD and ALSPAC, there was no association
between the cumulative ACE score and individual
CpG sites after multiple testing. In NSHD, DNA
methylation levels at three CpG sites were negatively
associated (FDR < 0.05) with a speciﬁc adversity; parental
mental illness (cg17164016 B=−0.07, p= 8.8 × 10–08,
FDR= 0.043), childhood illness (cg10303653 B=−0.017,
p= 2.1 × 10–08, FDR= 0.010) and child maltreatment
(cg14296561 B=−0.040, p= 6.5 ×–09, FDR= 0.003) (see
Table 2). Similar associations were found after adjusting
for smoking in the EWAS model (cg17164016 B=−0.07,
p= 2.5 × 10–07, FDR= 0.12; cg10303653 B=−0.016, p=
2.2 × 10–07, FDR= 0.11 and cg14296561 B=−0.043, p=
8.0 × 10–10, FDR= 0.0004). None of these associations
were replicated in ALSPAC, although cg14296561 was
weakly but positively (opposite direction of effect com-
pared with NSHD) associated with child maltreatment (B
= 0.0091, unadjusted p= 0.041) (see Table 2).
In ALSPAC, there was no associations of individual
CpG sites with any ACE measure after adjustment for
multiple tests (FDR < 0.05) (see Supplementary Figure 5
and 6 for QQ-plots of the EWAS analyses in NSHD and
ALSPAC, respectively).
Differentially methylated regions
We identiﬁed 231 differentially methylated regions
(DMRs; one-step Šidák correction <0.05) associated with
speciﬁc ACE measures in ALSPAC (n= 97) and NSHD
(n= 134). Four of the 134 NSHD DMRs replicated in
ALSPAC and six of the 97 ALSPAC DMRs replicated in
NSHD (same ACE measure and direction of effect;
StoufferLiptak-Kechris corrected P-value <0.05 unad-
justed for genome-wide tests), even after adjusting for
smoking (see Table 3 and Supplementary Table 7).
Of the nine replicated DMRs, the one (chr8:145654565-
145654855) DMR negatively associated with the ACE
score survived correction for multiple testing (Šidák cor-
rected p-value <0.05) and was thus discovered indepen-
dently in both cohorts, two DMRs were positively
(chr12:14720726-14721289) or negatively (chr1:3104999-
3105327) associated with parental mental illness, three
DMRs were either positively (chr15:40364524-40364863
and chr7:24323261-24323940) or negatively
(chr2:18766018-18766295) associated with parental death
and the last three DMRs were either positively
(chr15:81426347-81426670 and chr8:144120335-
144120707) or negatively (chr22:27834439-27834630)
associated with parental physical illness.
Only two of the eight DMRs associated with a speciﬁc
ACE were additionally associated with another ACE in
both cohorts (chr15:40364524-40364863 with parental
mental illness; chr8:144120335-144120707 with parental
death). In contrast, the DMR (chr8:145654565-
145654855) associated with the ACE score, was also
related to three speciﬁc ACEs (parental death, suboptimal
maternal bond and child maltreatment) in both cohorts
(see Table 3).
Besides the nine replicated DMRs, nineteen DMRs were
associated with the abuse and neglect childhood adversity
measures that were solely available in ALSPAC (3 DMRs
emotional abuse, 5 DMRs emotional neglect, 8 DMRs
physical abuse, 2 DMRs physical neglect and 1 DMR
sexual abuse) even after adjusting for smoking (see Sup-
plementary Table 8). Although these nineteen DMRs
could not be replicated in NSHD, the DMR on
chr3:87138203-87138701 was positively associated with
emotional neglect in ALSPAC as well as child maltreat-
ment in both ALSPAC and NSHD. Finally, the DMR on
chr11:67417958-67418406 was negatively associated with
several abuse and neglect measures in ALSPAC (emo-
tional neglect, emotional abuse and child maltreatment)
but did not replicate in NSHD where the DMR was
positively associated with child maltreatment.
Since there are DNA methylation proﬁles for many of
the same ALSPAC participants measured about 18 years
earlier during pregnancy (n= 769), we tested the 9
replicated DMRs for replication at that earlier time point.
Five of the 9 were replicated, including the single DMR
that survived genome-wide adjustment for multiple test-
ing in both cohorts (chr8:145654565-145654855). Details
are provided in Supplementary Table 9.
Enrichment for probes previously reported in literature
Although some of our top 1000 CpGs were enriched
for certain previously reported CpGs (1 CpG18, 4 CpGs11,
2 CpGs6, 2 CpGs15 and 2 CpGs10) (Supplementary Figure
7), in most cases the type of adversity in our analysis was
very different from the original study. Only three
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previously reported CpGs replicated (p < 0.05) and were
amongst the top 1000 CpGs of our analyses: (i)
cg19335412 near the ACTA2 gene that was previously
linked to childhood abuse6 and to sexual abuse in
ALSPAC (B= 0.039, p= 0.0014), (ii) cg00973947 near the
C3orf58 gene that was previously linked to the childhood
trauma questionnaire score10 and to ACE score in NSHD
(B= 0.001, p= 0.0014), and (iii) cg27347930 near the
LIG3 and CDS genes that was previously linked to sexual
abuse in the Dunedin study (B= -0.008, p= 2.39 ×
10−08)18 and also to sexual abuse in ALSPAC (B=
−0.016, p= 0.004).
There was some evidence for enrichment of smoking-
related associations38 and potentially unreliable
probes40,41 in our top CpGs (Supplementary Figure 7).
Cohort comparison
For all ACEs measured in both cohorts, the regression
coefﬁcients of the top 1000 CpGs were only weakly cor-
related between cohorts (Spearman ρ range between
−0.12 and 0.08, mean=−0.003, sd= 0.05) (see Supple-
mentary Figure 8). Furthermore, the average regression
coefﬁcients of the CpGs that are part of DMRs were also
only generally weakly and inconsistently correlated
between cohorts (ρ range between −0.59 and 0.60, mean
= 0.009, sd= 0.29) (see Supplementary Figure 9).
Cross-tissue analysis
In the NSHD subsample with both blood and buccal
cells (n= 98), the regression coefﬁcients of the top 1000
CpGs in the buccal EWAS were moderately to highly
correlated with the regression coefﬁcients of the same
CpGs in blood (Spearman ρ range= 0.20–0.59, mean=
0.50, sd= 0.13). Similar moderate to high cross-tissue
correlations were present for the top 1000 CpGs in the
blood EWAS analyses (ρ range= 0.36–0.69, mean= 0.54,
sd= 0.10) (see Supplementary Figure 10). The average
regression coefﬁcients of the CpGs that are part of DMRs
were also highly correlated across tissue type (ρ range=
0.66–0.95, mean= 0.85, sd= 0.12 for blood-based ACE
DMRs and ρ range= 0.45–0.86, mean= 0.73, sd= 0.15
for buccal-based ACE DMRs) (see Supplementary
Figure 11).
Inﬂuence of genetic variants on replicated DMRs
In ALSPAC, between eight and 40 genetic variants were
within 1MB and associated with at least one CpG for one
of the nine replicated DMRs (see Table 4). After adding
the appropriate genetic variants as covariates to the ori-
ginal EWAS model, the regression coefﬁcients for most
CpGs in the DMRs were in the same direction as the
original EWAS model and all DMRs were still statistically
signiﬁcant (one-step Šidák correction <0.05).
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Discussion
In this epigenome-wide study of childhood adversity in
two population-based cohorts of mid-life women, we
discovered nine novel differentially methylated genomic
regions (DMRs) but no individual CpGs that replicated
across cohorts. One DMR was associated with a measure
for cumulative adversity (ACE count score), whereas the
other eight regions were associated with speciﬁc types of
adversity, namely parental mental illness (two regions),
parental physical illness (three regions) and parental death
(three regions).
The most robust observation in this study was for a
DMR negatively associated with the ACE score, which
was also associated with parental death, suboptimal
maternal bonding and child maltreatment in ALSPAC
and NSHD. The DMR is located near a CpG island of the
promotor of the tonsoku-like DNA repair protein
(TONSL) gene (see Fig. 1), which is a histone chaperone
that may counteract chromatin compaction by preventing
the association between the histone H4 tail with the
H2A–H2B acidic patch on neighbouring nucleosomes42.
The DMRs related to a speciﬁc ACE tended to be related
to only one adversity, which is in line with a previous
study where different DNA methylation CpG sites were
affected by speciﬁc types of adversity compared to several
types of childhood adversity11. This appears to suggest
that certain parts of the methylome are associated with
distinct adverse childhood experiences, while other loca-
tions reﬂect more general exposure to adversity during
childhood.
The eight replicated DMRs related to a speciﬁc ACE
were all associated with parental health measures (par-
ental mental illness, parental physical illness and parental
death). This could indicate that parental health has a
bigger impact on the child’s epigenome than other types
of adversity. Alternatively, it may reﬂect intergenerational
transmission of health from parent to child with the
woman’s own health in turn inﬂuencing her epigenome.
Parental physical illness and parental death are linked to
six of the eight replicated DMRs. These ACEs have the
most similar prevalence in ALSPAC and NSHD suggest-
ing that similarity of measurements and hence effective
harmonisation across cohorts aided replication. Our lack
of associations for other measures of adversity is in line
Table 3 DMRs that replicated across cohorts
ACE DMR Nr CpGs Gene ALSPAC (Directiona,
p-value)
NSHD (Directiona,
p-value)
Replicated ACEs in
lookupb
ACE count score chr8: 145654565-
145654855
5 VPS28, TONSL -----
p= 7.5e−08*
-----
p= 1.8e−06*
ACE count score,
Parent died,
Maternal bond,
Child maltreatment
Parent mentally ill chr12: 14720726-
14721289
10 PLBD1 -++-++++++
p= 0.0058
+++++++++-
p= 9.5e−07*
Parent mentally ill
Parent mentally ill chr1: 3104999-
3105327
5 PRDM16 -----
p= 0.001
-----
p= 7.4e−08*
Parent mentally ill
Parent physically ill chr15: 81426347-
81426670
9 C15orf26 +++++++++
p= 0.011
+++++++++
p= 7.4e–07*
Parent mentally ill
Parent physically ill chr22: 27834439-
27834630
3 n/a ---
p= 6.9e−06*
---
p= 0.045
Parent mentally ill
Parent physically ill chr8: 144120335-
144120707
7 C8orf31 +++++++
p= 4.4e−06*
+++++++
p= 0.00092
Parent mentally ill,
Parent died
Parent died chr15: 40364524-
40364863
3 n/a +++
p= 6.3e−07*
+++
p= 0.0044
Parent died,
Parent mentally ill
Parent died chr7: 24323261-
24323940
9 NPY +++++++++
p= 9.2e−07*
+++++++++
p= 0.014
Parent died
Parent died chr2: 18766018-
18766295
4 NT5C1B ---+
p= 9.8e−06*
----
p= 0.014
Parent died
aDirection of effect for each individual CpG that is part of the DMR was derived from the regression coefﬁcient in the epigenome-wide analysis for individual CpGs
bIf the DMR additionally replicated for another ACE (same direction of effect and StoufferLiptak-Kechris corrected P-value <0.05 in both ALSPAC and NSHD), the
additional ACE is mentioned in this column
*DMR passed Šidák correction for multiple testing in comb-p
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with a recent epigenome-wide study reporting limited
evidence for an association between DNA methylation
and several forms of early-life victimisation stress18.
The replication of DMRs is noteworthy given the con-
siderable differences between ALSPAC and NSHD in
tissue type (blood or buccal), source of reporting (retro-
spective self-report or mother during childhood), and
years of birth (1950–1976 and 1946). The cohort differ-
ences may explain differences in adversity prevalence
which are known to be affected by source of reporting43–
45. Our own cross-cohort analyses also suggest cohort
differences may play a role, as the regression coefﬁcients
for the same ACE exposure did not correlate across
cohorts but were correlated between tissue types within
the same cohort despite large, genome-wide DNA
methylation differences between tissues46. Furthermore,
our genetic analysis does not indicate the methylation
differences at the DMRs are driven solely by genetic
variation, as the direction of effect for the individual CpGs
is similar and the DMRs remain signiﬁcant after adjusting
for genetic variants within 1MB of the DMR.
Our tissue comparison showed medium to high corre-
lation across buccal and blood tissue for CpGs and DMRs
associated with the same ACE, whereas the cross-tissue
correlation was lower for different ACEs. This suggests
similar childhood adversity related DNA methylation
changes could be identiﬁed in blood and buccal tissue.
Some recommend buccal samples for population epige-
netic studies, as they contain more hypomethylated DNA
regions, which tend to cluster around disease-associated
SNPs;47 others, however, argue that demographic factors
may be better reﬂected in blood DNA methylation pat-
terns46. Identifying DMRs that are associated in both
tissue types supports the robustness of our ﬁndings.
Although the non-replication of the three CpGs that
survived FDR correction in NSHD could be related to
cohort differences, the distribution of the p-values also
suggests that there were no associations or we were
underpowered to identify individual CpGs in each cohort
(Supplementary Figure 5 and 6) even though smaller case-
control studies previously reported evidence for associa-
tions11,13,15. Although selection bias—with the DNA
methylation sample being slightly more afﬂuent than the
full cohort—may bias results towards the null48, in our
study most of the ACEs had similar prevalence estimates
in the DNA methylation subsample, suggesting selection
bias is not likely to have affected our ﬁndings. One
potential explanation for the contrast between ﬁndings in
Table 4 Inﬂuence of genetic variants near the replicated DMRs in ALSPAC
ACE DMR Nr CpGs Gene Original analysis
(Directiona, p-value)
Nr SNPs (within 1MB,
associated one CpG (p
< 0.05))
Sample size Sensitivity analysis,
including SNPs
(Directiona, p-value)b
ACE count
score
chr8: 145654565-
145654855
5 VPS28,
TONSL
-----
p= 7.5e−08*
8 618 -----
p= 0.0020
Parent
mentally ill
chr12: 14720726-
14721289
10 PLBD1 -++-++++++
p= 0.0058
28 532 --+±++++++
p= 0.0496
Parent
mentally ill
chr1: 3104999-
3105327
5 PRDM16 -----
p= 0.001
16 672 -----
p= 0.001
Parent
physically ill
chr15: 81426347-
81426670
9 C15orf26 +++++++++
p= 0.011
20 609 +++++++++
p= 0.0010
Parent
physically ill
chr22: 27834439-
27834630
3 n/a ---
p= 6.9e−06*
35 686 ---
p= 1.207e−05*
Parent
physically ill
chr8: 144120335-
144120707
7 C8orf31 +++++++
p= 4.4e−06*
13 673 +++++++
p= 7.998e−05*
Parent died chr15: 40364524-
40364863
3 n/a +++
p= 6.3e−07*
19 605 +++
p= 8.915e−06*
Parent died chr7: 24323261-
24323940
9 NPY +++++++++
p= 9.2e−07*
40 584 +++++-+++
p= 0.0005
Parent died chr2: 18766018-
18766295
4 NT5C1B ---+
p= 9.8e−06*
27 520 -± --
p= 0.0289
aDirection of effect for each individual CpG that is part of the DMR was derived from the regression coefﬁcients for individual CpGs
bThe CpGs with a different direction of effect in the sensitivity analysis are underlined and in red.
*DMR passed Šidák correction for multiple testing in comb-p
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case-control studies and the lack of individual CpGs in
this and other population-based cohort studies is that
childhood adversity related DNA methylation differences
are more subtle in population-based cohorts compared to
high risk case-control designs due to differences in
severity of the adversity exposures and the instruments
used to assess childhood adversity. These differences may
also explain the lack of enrichment of most previously
identiﬁed CpGs in our population-based cohorts. In this
context, it is striking that the most robust enrichment was
for the Dunedin study, another population-based cohort
study18. Here, one out of two CpGs associated with sexual
abuse replicated in ALSPAC. Note that enrichment in
NSHD could not be determined due to a lack of sexual
abuse data. The Dunedin cohort had the most similarities
to our ALSPAC sample: retrospectively reported sexual
abuse exposure between 0–16 years in a relatively large
(~800) population-based birth cohort sample, with DNA
methylation assessed in mid-life.
Overall, we ﬁnd evidence that adverse childhood
experiences, particularly those related to parental health,
can have long-term effects on peripheral DNA
methylation in mid-life. We ﬁnd some evidence to repli-
cate a previously identiﬁed CpG site associated with
sexual abuse.
Code availability
Code to generate these results is available from the
authors on request.
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